
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11956082
[patent_doc_number] => 20170260232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE'
[patent_app_type] => utility
[patent_app_number] => 15/602156
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 28688
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602156
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602156 | TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE | May 22, 2017 | Abandoned |
Array
(
[id] => 12259411
[patent_doc_number] => 20180078606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 15/585320
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6018
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585320
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585320 | METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS | May 2, 2017 | Abandoned |
Array
(
[id] => 14342161
[patent_doc_number] => 20190153053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT)
[patent_app_type] => utility
[patent_app_number] => 16/097582
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097582 | PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT) | Apr 27, 2017 | Abandoned |
Array
(
[id] => 15365989
[patent_doc_number] => 20200018759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => DIAGNOSTIC METHOD OF LIVER CANCER USING ALPHA-FETOPROTEIN DERIVED GLYCOPEPTIDES BY MASS SPECTROMETRY
[patent_app_type] => utility
[patent_app_number] => 15/545552
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545552 | Diagnostic method of liver cancer using a-fetoprotein derived glycopeptides by mass spectrometry | Apr 26, 2017 | Issued |
Array
(
[id] => 11992474
[patent_doc_number] => 20170296628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'PEGYLATED BIOACTIVE PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/490618
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12539
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490618 | Pegylated bioactive peptides and uses thereof | Apr 17, 2017 | Issued |
Array
(
[id] => 12464481
[patent_doc_number] => 09986733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Compositions and methods for reducing ice crystal formation
[patent_app_type] => utility
[patent_app_number] => 15/486522
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 27
[patent_no_of_words] => 22893
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486522 | Compositions and methods for reducing ice crystal formation | Apr 12, 2017 | Issued |
Array
(
[id] => 11757287
[patent_doc_number] => 20170204155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'PEPTIDE ANTAGONISTS OF THE CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/478053
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18743
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478053 | Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use | Apr 2, 2017 | Issued |
Array
(
[id] => 16984556
[patent_doc_number] => 11071706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium
[patent_app_type] => utility
[patent_app_number] => 16/089510
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5394
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089510
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089510 | Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium | Mar 30, 2017 | Issued |
Array
(
[id] => 11823185
[patent_doc_number] => 20170212120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'SELECTED REACTION MONITORING ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 15/476118
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17536
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476118
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476118 | Selected reaction monitoring assays | Mar 30, 2017 | Issued |
Array
(
[id] => 13968305
[patent_doc_number] => 10213486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Formulations of diluted amino acid segments and methods for making same
[patent_app_type] => utility
[patent_app_number] => 15/470239
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13877
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470239 | Formulations of diluted amino acid segments and methods for making same | Mar 26, 2017 | Issued |
Array
(
[id] => 11971196
[patent_doc_number] => 20170275350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 15/470117
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21123
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470117 | Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods | Mar 26, 2017 | Issued |
Array
(
[id] => 11742866
[patent_doc_number] => 20170196938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 15/470169
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14465
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470169 | Carrier-free biologically-active protein nanostructures | Mar 26, 2017 | Issued |
Array
(
[id] => 11727955
[patent_doc_number] => 20170189398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/467867
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12396
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467867
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467867 | Methods and compositions for sleep disorders and other disorders | Mar 22, 2017 | Issued |
Array
(
[id] => 14145463
[patent_doc_number] => 10253090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Hydrolyzed collagen compositions and methods of making thereof
[patent_app_type] => utility
[patent_app_number] => 15/569240
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4979
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569240 | Hydrolyzed collagen compositions and methods of making thereof | Mar 19, 2017 | Issued |
Array
(
[id] => 11977619
[patent_doc_number] => 20170281774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'LINACLOTIDE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/461923
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14671
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461923 | LINACLOTIDE COMPOSITIONS | Mar 16, 2017 | Abandoned |
Array
(
[id] => 16596726
[patent_doc_number] => 20210023257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => CEREBROSPINAL FLUID LEAKAGE OCCLUSION
[patent_app_type] => utility
[patent_app_number] => 16/085803
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085803 | CEREBROSPINAL FLUID LEAKAGE OCCLUSION | Mar 16, 2017 | Abandoned |
Array
(
[id] => 18153084
[patent_doc_number] => 11566045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Tumor targeting polypeptide and method of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/562722
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9976
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562722 | Tumor targeting polypeptide and method of use thereof | Mar 13, 2017 | Issued |
Array
(
[id] => 16288803
[patent_doc_number] => 10765625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Knottin-drug conjugates and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 15/458852
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 12562
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458852 | Knottin-drug conjugates and methods of using the same | Mar 13, 2017 | Issued |
Array
(
[id] => 12023645
[patent_doc_number] => 20170313745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/455508
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52232
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455508
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455508 | INHIBITORS OF HEPATITIS C VIRUS | Mar 9, 2017 | Abandoned |
Array
(
[id] => 16042935
[patent_doc_number] => 10683326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Crystalline salt forms
[patent_app_type] => utility
[patent_app_number] => 16/084168
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 25022
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084168 | Crystalline salt forms | Mar 9, 2017 | Issued |